Healthcare (SH:603313) Xin Lang Cai Jing·2025-11-18 05:31Core Viewpoint - The stock of Dream Lily has experienced fluctuations, with a recent decline of 2.06% and a year-to-date increase of 34.78%, indicating volatility in its market performance [1][2]. Group 1: Stock Performance - As of November 18, Dream Lily's stock price is 9.03 CNY per share, with a total market capitalization of 5.152 billion CNY [1]. - The stock has seen a net outflow of 6.6769 million CNY in principal funds, with significant selling pressure from large orders [1]. - Over the past five trading days, the stock has decreased by 3.22%, while it has increased by 7.12% over the past 60 days [1]. Group 2: Company Overview - Dream Lily, established on May 30, 2003, and listed on October 13, 2016, specializes in home products aimed at enhancing deep sleep, including memory foam mattresses and pillows [2]. - The revenue composition includes memory foam mattresses (52.06%), sofas (13.12%), and other products, indicating a diverse product range [2]. - As of September 30, the company had 24,100 shareholders, with an average of 23,651 circulating shares per shareholder [2]. Group 3: Financial Performance - For the period from January to September 2025, Dream Lily reported a revenue of 6.756 billion CNY, reflecting a year-on-year growth of 10.29%, and a net profit of 161 million CNY, marking a significant increase of 205.18% [2]. - The company has distributed a total of 546 million CNY in dividends since its A-share listing, with 28.5293 million CNY in the last three years [3]. Group 4: Institutional Holdings - As of September 30, 2025, major institutional shareholders include Hua'an Ankang Flexible Allocation Mixed Fund and others, with some institutions reducing their holdings while new ones have entered [3].